Quanta, a cutting-edge technology platform that applies advances in quantum biology, agreed to acquire a 51% stake in Medolife, a pharmaceutical company. Financial terms were not disclosed. "We are extremely pleased to announce this monumental moment in the story of Quanta, with this acquisition of 51% of Medolife Rx. Dr. Mikaelian is a true pioneer in the space, and we believe that together we will be able to take this technology to heights we could not have reached alone," Phil Sands, Quanta CEO.